AR039171A1 - Co-granulos de dha y romero y metodos de uso - Google Patents

Co-granulos de dha y romero y metodos de uso

Info

Publication number
AR039171A1
AR039171A1 ARP030101083A ARP030101083A AR039171A1 AR 039171 A1 AR039171 A1 AR 039171A1 AR P030101083 A ARP030101083 A AR P030101083A AR P030101083 A ARP030101083 A AR P030101083A AR 039171 A1 AR039171 A1 AR 039171A1
Authority
AR
Argentina
Prior art keywords
dha
romero
granules
methods
rosemary
Prior art date
Application number
ARP030101083A
Other languages
English (en)
Spanish (es)
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28675473&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR039171(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AR039171A1 publication Critical patent/AR039171A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
ARP030101083A 2002-03-28 2003-03-27 Co-granulos de dha y romero y metodos de uso AR039171A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36835202P 2002-03-28 2002-03-28

Publications (1)

Publication Number Publication Date
AR039171A1 true AR039171A1 (es) 2005-02-09

Family

ID=28675473

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101083A AR039171A1 (es) 2002-03-28 2003-03-27 Co-granulos de dha y romero y metodos de uso

Country Status (11)

Country Link
US (2) US20050147698A1 (https=)
EP (1) EP1487418B1 (https=)
JP (2) JP2005527551A (https=)
AR (1) AR039171A1 (https=)
AT (1) ATE398445T1 (https=)
AU (1) AU2003220417B2 (https=)
BR (1) BR0308713A (https=)
CA (1) CA2478154A1 (https=)
DE (1) DE60321669D1 (https=)
DK (1) DK1487418T3 (https=)
WO (1) WO2003082249A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7239755B1 (en) * 1997-07-30 2007-07-03 Lg Electronics Inc. Method of reducing a blocking artifact when coding moving picture
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7666449B2 (en) 2001-06-20 2010-02-23 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
DK1487418T3 (da) * 2002-03-28 2008-09-15 Alcon Inc Lille CO-perle af DHA og rosmarin samt fremgangsmåder til anvendelse
AR039170A1 (es) * 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso
NZ543726A (en) 2003-05-22 2009-08-28 Metaproteomics Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
FR2882894B1 (fr) * 2005-03-11 2009-04-03 Larena Sa Composition alimentaire suppletive
CA2618613A1 (en) * 2005-08-09 2007-02-22 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
ES2277557B1 (es) * 2005-12-21 2008-07-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
NZ579340A (en) 2007-03-19 2012-05-25 Metaproteomics Llc Methods and compositions for promoting bone and joint health comprising berberine
US8652544B2 (en) * 2008-01-11 2014-02-18 U.S. Nutraceuticals, LLC Chia seed composition
AU2011211461B2 (en) * 2008-01-11 2011-11-17 U.S. Nutraceuticals, Llc D/B/A Valensa International Chia seed composition
US20100159029A1 (en) * 2008-12-23 2010-06-24 Alcon Research, Ltd. Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response
JP5560017B2 (ja) * 2009-10-13 2014-07-23 旭化成ケミカルズ株式会社 脂肪酸、トリグリセリドまたはその混合物を含むマルチコアマイクロカプセルを含有する錠剤およびその製法
WO2011057183A1 (en) 2009-11-06 2011-05-12 Alcon Research, Ltd. Nutritional supplements for relief of dry eye

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
CH627449A5 (de) * 1977-03-25 1982-01-15 Hoffmann La Roche Verfahren zur herstellung von mikrokristallinem vitamin a-acetat, sowie von trockenen, frei-fliessenden praeparaten, in welchen vitamin a-acetat in mikrokristalliner form vorliegt.
AU552068B2 (en) * 1981-09-21 1986-05-22 Asama Chemical Co. Ltd. Preservation of edible oils
US4670247A (en) * 1983-07-05 1987-06-02 Hoffman-Laroche Inc. Process for preparing fat-soluble vitamin active beadlets
DK88692D0 (da) * 1992-07-06 1992-07-06 Danochemo As Fremgangsmaade til fremstilling af mikrokapsler
JPH0892129A (ja) * 1993-10-08 1996-04-09 Kanagawa Kagaku Kenkyusho:Kk 眼発作治療薬
JPH07236418A (ja) * 1994-02-25 1995-09-12 Kanegafuchi Chem Ind Co Ltd ドコサヘキサエン酸、エイコサペンタエン酸用抗酸化矯臭剤
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
JP3545148B2 (ja) * 1996-01-08 2004-07-21 味の素株式会社 食用マイクロカプセル及びそれを含有する食品
JPH1029938A (ja) * 1996-07-17 1998-02-03 Maruha Corp 虚血性眼疾患の予防および／または治療剤
JP3640005B2 (ja) * 1996-09-25 2005-04-20 日本たばこ産業株式会社 ソフトカプセル用皮膜
JP4028020B2 (ja) * 1997-02-17 2007-12-26 株式会社紀文フードケミファ 動体視力改善剤
JPH10286079A (ja) * 1997-04-16 1998-10-27 Yasumasa Morita 薬草ハーブと不飽和脂肪酸ｄ．ｈ．ａ（ドコサヘキ サエン酸）を混入した海産物海苔
JP4028642B2 (ja) * 1997-10-07 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 乳化粉末の製造方法
EP0958828A1 (de) * 1998-05-22 1999-11-24 Greither, Peter Präparat auf der Basis der Artischockenpflanze, insbesondere zur Verwendung als Arzneimittel oder Nahrungsergänzungsmittel
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
US6582721B1 (en) * 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
DE20205184U1 (de) 2002-03-27 2002-12-19 Bartz, Volker, 35440 Linden Blutfettsenker zur oralen Einnahme
DK1487418T3 (da) * 2002-03-28 2008-09-15 Alcon Inc Lille CO-perle af DHA og rosmarin samt fremgangsmåder til anvendelse
AR039170A1 (es) * 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso

Also Published As

Publication number Publication date
BR0308713A (pt) 2005-01-04
WO2003082249A1 (en) 2003-10-09
ATE398445T1 (de) 2008-07-15
EP1487418B1 (en) 2008-06-18
US20080152710A1 (en) 2008-06-26
HK1070558A1 (en) 2005-06-24
EP1487418A1 (en) 2004-12-22
EP1487418A4 (en) 2005-07-13
JP2006077024A (ja) 2006-03-23
CA2478154A1 (en) 2003-10-09
JP2005527551A (ja) 2005-09-15
AU2003220417B2 (en) 2009-03-12
AU2003220417A1 (en) 2003-10-13
US20050147698A1 (en) 2005-07-07
DE60321669D1 (de) 2008-07-31
DK1487418T3 (da) 2008-09-15

Similar Documents

Publication Publication Date Title
AR039170A1 (es) Co-granulos de dha y romero y metodos de uso
AR039171A1 (es) Co-granulos de dha y romero y metodos de uso
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
CO2018011299A2 (es) Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
CL2019001471A1 (es) Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción.
MX2021004999A (es) Administracion de butirato, beta-hidroxibutirato, cannabidiol y compuestos relacionaods en seres humanos.
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
GB0314624D0 (en) Inflammatory disease treatment
CL2019002190A1 (es) Reducción de la viscosidad de formulaciones farmacéuticas que comprende una proteína terapéutica a una concentración de al menos 70 mg/ml, donde la proteína terapéutica no es un anticuerpo (divisional solicitud 201700984)
AR060387A1 (es) Suplementos alimenticios y sus usos
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
NO20075009L (no) Ernaeringstilsetning for HIV-pasienter
EA200800451A1 (ru) Лечение дигидропиридиновыми блокаторами кальциевых каналов и жирными кислотами омега-3 и их комбинированным продуктом
PH12012502279A1 (en) Tube feed formulations and methods for using same
AR052238A1 (es) Formulacion de tabletas estables
CL2019001366A1 (es) Formulaciones tamponadas exendina (9-39).
EA201001283A1 (ru) Комбинация витамина d и 25-гидроксивитамина d3
ECSP066670A (es) Prodroga florfenicol con mejor solubilidad en agua
AR105237A1 (es) Método y composiciones nutricionales que contienen fosfatidiletanolamina, esfingomielina y ácido docosahexaenoico
PH12020550778A1 (en) Formulations for nutritional support in subjects in need thereof
AR054255A1 (es) Tratamiento de la disfuncion intestinal enpacientes con hiv
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
ATE417090T1 (de) Stabilisierung von esterkonzentraten von mehrfach ungesättigten fettsäuren
MY209656A (en) Compositions and methods of enhancing 5-hydroxytryptophan bioavailability

Legal Events

Date Code Title Description
FB Suspension of granting procedure